Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Other
  • Drug Channels News Roundup, March 2026: Cigna’s 340B Workaround, Merck’s ARPA Surprise, Walgreens’ Automation Bet, Why Rebates Hurt Patients, and a DCI Team Photo
  • Other

Drug Channels News Roundup, March 2026: Cigna’s 340B Workaround, Merck’s ARPA Surprise, Walgreens’ Automation Bet, Why Rebates Hurt Patients, and a DCI Team Photo

Drug Channels

Spring is here in always-sunny Philadelphia.

OtherRead full story

pharminent March 31, 2026 (Last updated: March 31, 2026)

Drug Channels

Spring is here in always-sunny Philadelphia.

OtherRead full story

Post navigation

Previous: Biotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026
Next: UCB brings first therapy for rare disease TK2d to EU

Related Stories

  • Other

Takeda and Weave Bio collaborate on AI-driven automation in drug development

pharminent September 2, 2026
  • Other

ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer

pharminent June 2, 2026
  • Other

ASCO26: Symptom-tracking app helps advanced cancer patients

pharminent June 2, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.